PubMed:15737842 / 0-340 JSONTXT

{"project":"c_corpus","denotations":[{"id":"T3","span":{"begin":0,"end":24},"obj":"D002285"},{"id":"T4","span":{"begin":0,"end":24},"obj":"D002285"},{"id":"T9","span":{"begin":32,"end":38},"obj":"UBERON:0000310"},{"id":"T12","span":{"begin":43,"end":53},"obj":"C038253"},{"id":"T17","span":{"begin":43,"end":55},"obj":"Q9Y251"},{"id":"T18","span":{"begin":43,"end":55},"obj":"PR:000008741"},{"id":"T21","span":{"begin":134,"end":158},"obj":"D002285"},{"id":"T22","span":{"begin":134,"end":158},"obj":"D002285"},{"id":"T27","span":{"begin":166,"end":172},"obj":"UBERON:0000310"},{"id":"T29","span":{"begin":174,"end":178},"obj":"CVCL_5552"},{"id":"T28","span":{"begin":174,"end":178},"obj":"D002285"},{"id":"T30","span":{"begin":174,"end":178},"obj":"D002285"},{"id":"T33","span":{"begin":278,"end":288},"obj":"C038253"},{"id":"T38","span":{"begin":278,"end":290},"obj":"Q9Y251"},{"id":"T39","span":{"begin":278,"end":290},"obj":"PR:000008741"},{"id":"T52","span":{"begin":292,"end":296},"obj":"Q9C9W5"},{"id":"T53","span":{"begin":292,"end":296},"obj":"PR:000008741"},{"id":"T54","span":{"begin":292,"end":296},"obj":"PR:Q8R3N6"},{"id":"T55","span":{"begin":292,"end":296},"obj":"PR:Q93VM9"},{"id":"T56","span":{"begin":292,"end":296},"obj":"PR:Q9Y251"},{"id":"T57","span":{"begin":292,"end":296},"obj":"PR:Q96FV9"},{"id":"T58","span":{"begin":292,"end":296},"obj":"PR:P17629"},{"id":"T59","span":{"begin":292,"end":296},"obj":"PR:000016310"},{"id":"T60","span":{"begin":292,"end":296},"obj":"PR:G5EC44"}],"text":"Ductal carcinoma in situ of the breast and heparanase-1 expression: a molecular explanation for more aggressive subtypes.\nBACKGROUND: Ductal carcinoma in situ of the breast (DCIS) forms a heterogeneous group of lesions with varying invasive potential. This study tested whether heparanase-1 (HPR1), an endoglycosidase that specifically degr"}

{"project":"UseCases_ArguminSci_Discourse","denotations":[{"id":"T1","span":{"begin":0,"end":121},"obj":"DRI_Background"},{"id":"T2","span":{"begin":131,"end":251},"obj":"DRI_Background"}],"text":"Ductal carcinoma in situ of the breast and heparanase-1 expression: a molecular explanation for more aggressive subtypes.\nBACKGROUND: Ductal carcinoma in situ of the breast (DCIS) forms a heterogeneous group of lesions with varying invasive potential. This study tested whether heparanase-1 (HPR1), an endoglycosidase that specifically degr"}

{"project":"DisGeNET5_gene_disease","denotations":[{"id":"15737842-0#43#55#gene10855","span":{"begin":43,"end":55},"obj":"gene10855"},{"id":"15737842-0#0#38#diseaseC0007124","span":{"begin":0,"end":38},"obj":"diseaseC0007124"}],"relations":[{"id":"43#55#gene108550#38#diseaseC0007124","pred":"associated_with","subj":"15737842-0#43#55#gene10855","obj":"15737842-0#0#38#diseaseC0007124"}],"text":"Ductal carcinoma in situ of the breast and heparanase-1 expression: a molecular explanation for more aggressive subtypes.\nBACKGROUND: Ductal carcinoma in situ of the breast (DCIS) forms a heterogeneous group of lesions with varying invasive potential. This study tested whether heparanase-1 (HPR1), an endoglycosidase that specifically degr"}

{"project":"DisGeNET","denotations":[{"id":"T0","span":{"begin":43,"end":55},"obj":"gene:10855"},{"id":"T1","span":{"begin":0,"end":38},"obj":"disease:C0007124"}],"relations":[{"id":"R1","pred":"associated_with","subj":"T0","obj":"T1"}],"namespaces":[{"prefix":"gene","uri":"http://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"disease","uri":"http://purl.bioontology.org/ontology/MEDLINEPLUS/"}],"text":"Ductal carcinoma in situ of the breast and heparanase-1 expression: a molecular explanation for more aggressive subtypes.\nBACKGROUND: Ductal carcinoma in situ of the breast (DCIS) forms a heterogeneous group of lesions with varying invasive potential. This study tested whether heparanase-1 (HPR1), an endoglycosidase that specifically degr"}